Blair C. Jackson is a seasoned executive who currently holds the position of Executive Vice President, Chief Operating Officer, and Chief Risk Officer at Alkermes, a global biopharmaceutical company. With over two decades of experience in the biopharmaceutical industry, Jackson has a proven track record of leadership and strategic vision. Before joining Alkermes, he held various senior leadership roles at other prominent biopharmaceutical companies, where he was instrumental in driving operational excellence and managing complex risk environments. At Alkermes, Jackson plays a pivotal role in overseeing the company's operations and risk management strategies. His responsibilities include ensuring the efficient and compliant execution of the company's manufacturing, supply chain, and quality assurance functions. Jackson's leadership has been crucial in advancing Alkermes' mission to develop innovative medicines for patients suffering from serious chronic diseases. Under his guidance, the company has successfully navigated the challenges of scaling up production and maintaining high standards of quality and safety. Jackson's achievements at Alkermes are a testament to his dedication and expertise. He has been recognized for his ability to foster a culture of continuous improvement and innovation within the organization. His strategic oversight has helped Alkermes to strengthen its position in the competitive biopharmaceutical market, ensuring the company's long-term success and its ability to deliver life-changing therapies to patients worldwide.